Pulse Biosciences Says NANOPULSE-AF Atrial Fibrillation Study Surpasses Enrollment Midpoint After April 2026 Start; Update Due On August 6 Earnings Call

뉴스 본문을 불러오고 있어요.

Pulse Biosciences Says NANOPULSE-AF Atrial Fibrillation Study Surpasses Enrollment Midpoint After April 2026 Start; Update Due On August 6 Earnings Call | 웨이프 WAPE

Pulse Biosciences Says NANOPULSE-AF Atrial Fibrillation Study Surpasses Enrollment Midpoint After April 2026 Start; Update Due On August 6 Earnings Call

기사 요약

관련 종목

댓글 —